Navigation Links
Myoderm Selects Tracie DiPasquale To Lead CentralSource
Date:1/8/2013

Norristown, PA (PRWEB) January 08, 2013

Myoderm, a global leader in sourcing commercial drugs for clinical trials, is pleased to announce that Tracie DiPasquale has joined the company as Director, CentralSource. She will work out of Myoderm’s US office.

Myoderm is fortunate to have someone with Tracie’s background and qualifications to direct CentralSource, the company’s turnkey sourcing, distribution, and management service that supplies individual sites directly on an as-needed basis. For over a decade, she managed business development efforts and implemented supply chain strategies for leading pharmaceutical firms, including Pfizer and Almac. Her diversified experience with both large and small pharmaceutical companies gives her the insight and flexibility to exceed clients’ needs.

A graduate of the University of Pittsburgh, with a B.Sc. degree in Natural Sciences and a minor in Biology, Tracie offers Myoderm customers a unique understanding of global clinical site drug supply management and oversight issues.

Mike Cohen, Managing Director of Myoderm, says, “Tracie’s experience from both the service and client sides gives her an invaluable perspective on sourcing issues and makes her a superb advocate for Myoderm clients.”

About Myoderm
Myoderm is a leader in the sourcing, distribution, and management of commercial pharmaceutical products and supplies for clinical trials and biosimilar research. The company’s clients span the globe and include biotech, CROs, clinical trial packagers, and the majority of the world’s top10 pharmaceutical companies. With its deep expertise, customized solutions, and commitment to personalized service, Myoderm provides the optimal drug supply solution for global clinical studies.

Read the full story at http://www.prweb.com/releases/2013/1/prweb10292730.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. UCAN Selects Defran Systems to Support its Wide Range of Youth and Family Programs
2. President Obama selects Rutgers cell biologist Nihal Altan-Bonnet to receive prestigious award
3. The Gerontological Society of America Selects 2012 Fellows
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2017)... MN (PRWEB) , ... January 14, 2017 , ... ... present the distinctions among their expanding line of activated charcoal products. With more ... the importance of categorizing their products according to how they cater to specific ...
(Date:1/14/2017)... ... ... 3 is a self animating masking transition which allows users to reveal any object or ... - CEO of Pixel Film Studios. , TransFreeze Volume 3 provides FCPX ... next. , To use “Cut-Out First” presets, choose a video clip and hold ...
(Date:1/13/2017)... ... January 13, 2017 , ... A January 10 article ... for 2017 according to the publication, with an emphasis on some new techniques that ... F.I.C.S., F.A.C.S., who is known more casually to his patients and colleagues as Dr. ...
(Date:1/13/2017)... ... ... inventor from Pahrump, Nev., used an unsavory medical experience to think of a way to ... urine bag for a half year due to lazy bladder," he said. "Keeping these things ... better way to do this." , He then designed and created a prototype of the ...
(Date:1/13/2017)... PA (PRWEB) , ... January 13, 2017 , ... "We ... and attractive to wear," said one of two inventors from Virginia Beach, Va. , ... to normally mundane braces. , The accessories allow braces to be customized to ...
Breaking Medicine News(10 mins):
(Date:1/13/2017)... Idaho , Jan. 12, 2017  Albertsons ... by Accreditation Commission for Health Care (ACHC) for ... largest national food and drug chain with this ... for pharmacy patients. Accreditation by ACHC ... national standards to facilitate a higher level of ...
(Date:1/13/2017)... Jan. 13, 2017  Biologics Prescribers Collaborative ... Administration (FDA) for issuing final guidance calling ... This policy is an important win for ... essential for pharmacovigilance, patient safety and transparency. ... voiced to FDA, we remain concerned with "random" suffixes ...
(Date:1/12/2017)... COTTAGE, New York , January 12, 2017 ... to observe steady growth in 2016, reaching beyond US$ 3.8 Bn ... diagnosis, and treatment is anticipated to fuel the demand for PIVC. ... market growth. North America is likely to ... expected to emerge at the fastest rate. ...
Breaking Medicine Technology: